I wonder if this is not the announcement promised regarding capital requirements. That's how I read it but you never k ow. Either way, if a capital raising is required it will be minor and at a better time in the companies progress.
I could be wrong but I think any capital raising (if needed) will be delayed until after the initial unblinded HSV 2 results are released. That would make much more sense.
The New Admedus, page-49
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.09 |
Change
-0.110(0.90%) |
Mkt cap ! $255.5M | |||
| Open | High | Low | Value | Volume |
| $12.19 | $12.19 | $11.60 | $117.1K | 9.871K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 80 | $11.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.09 | 120 | 1 |
View Market Depth
| Last trade - 13.42pm 01/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |